Euronext Dublin Euronext Growth Dublin Cancellation Notice (0792F)

TIDMAMYT

RNS Number : 0792F

Euronext Dublin

11 July 2019

 
CORPORATE EVENT NOTICE:  Cancellation Notice 
                         AMRYT PHARMA PLC 
 
LOCATION:                Dublin 
 
DATE:                    11th July 2019 
MARKET:                  Euronext Growth Dublin 
 

CANCELLATION NOTICE

Trading of the under mentioned security has been cancelled with effect from 8.00am 11th July 2019 on Euronext Growth Dublin.

AMRYT PHARMA PLC

274,817,282 Ordinary Shares EUR0.01

GB00BDD1LS57

Equity

This announcement has been issued through the Companies Announcement Service of

Euronext Dublin.

The present notice and the contents thereof are only provided for information purposes in order to facilitate the fair, orderly and efficient functioning of the market and is not a recommendation to engage in investment activities. The contents of this notice are provided "as is" based on information provided to the market operator without representation or warranty of any kind. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this notice shall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext's subsidiaries shall depend solely on the applicable rules of the market operator.

The Euronext Markets comprise the markets operated by Euronext Amsterdam, Euronext Brussels, Euronext Dublin, Euronext Lisbon, Euronext Paris and Euronext UK Markets, referred to respectively as the Amsterdam, Brussels, Dublin, Lisbon, Paris and London markets, as relevant.

Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at https://www.euronext.com/terms-use.

(c) 2019 Euronext N.V. - All rights reserved

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ISEDMGMNRGKGLZG

(END) Dow Jones Newswires

July 11, 2019 02:59 ET (06:59 GMT)